| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GZD824 |
|---|
| Description | GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively. MW: 532.56. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-Methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide |
|---|
| Gene, Accession, CAS # | CAS: 1257628-77-5 |
|---|
| Catalog # | 2795-25 |
|---|
| Price | |
|---|
| Order / More Info | GZD824 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|